Feasibility of reduced-dose posttransplant cyclophosphamide and cotransplantation of peripheral blood stem cells and umbilical cord-derived mesenchymal stem cells for SAA
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Feasibility of reduced-dose posttransplant cyclophosphamide and cotransplantation of peripheral blood stem cells and umbilical cord-derived mesenchymal stem cells for SAA ; volume:11 ; number:1 ; day:8 ; month:1 ; year:2021 ; pages:1-11 ; date:12.2021
Scientific reports ; 11, Heft 1 (8.1.2021), 1-11, 12.2021
- Creator
-
Zu, Yingling
Zhou, Jian
Fu, Yuewen
Fang, Baijun
Liu, Xinjian
Zhang, Yanli
Yu, Fengkuan
Zuo, Wenli
Zhou, Hu
Gui, Ruirui
Li, Zhen
Liu, Yanyan
Zhao, Huifang
Zhang, Chengjuan
Song, Yongping
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-020-80531-7
- URN
-
urn:nbn:de:101:1-2021020602491140232292
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zu, Yingling
- Zhou, Jian
- Fu, Yuewen
- Fang, Baijun
- Liu, Xinjian
- Zhang, Yanli
- Yu, Fengkuan
- Zuo, Wenli
- Zhou, Hu
- Gui, Ruirui
- Li, Zhen
- Liu, Yanyan
- Zhao, Huifang
- Zhang, Chengjuan
- Song, Yongping
- SpringerLink (Online service)
Other Objects (12)
ATG or post-transplant cyclophosphamide to prevent GVHD in matched unrelated stem cell transplantation?
Post-transplant cyclophosphamide alters immune signatures and leads to impaired T cell reconstitution in allogeneic hematopoietic stem cell transplant
Strategies in umbilical cord-derived mesenchymal stem cells expansion
Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide for T-Cell Prolymphocytic Leukemia after Alemtuzumab Induction Therapy: A Case Report
Haploidentical Hematopoietic Cell Transplantation Using Posttransplant Cyclophosphamide for Sézary Syndrome
Donor’s age influences outcome in haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide - a single center experience
Umbilical cord-derived mesenchymal stem cell sheets transplanted subcutaneously enhance cell retention and survival more than dissociated stem cell injections
Haploidentical Hematopoietic Stem Cell Transplantation Followed by ‘Post-Cyclophosphamide’: The Future of Allogeneic Stem Cell Transplant
Dual T-cell depletion with individually tailored anti-thymocyte globulin and attenuated dose of post-transplant cyclophosphamide in haploidentical peripheral stem cell transplantation
Post-transplant cyclophosphamide and sirolimus based graft-versus-host disease prophylaxis after allogeneic stem cell transplantation for acute myeloid leukemia
Platelet lysate induces chondrogenic differentiation of umbilical cord-derived mesenchymal stem cells
Human umbilical cord-derived mesenchymal stem cells attenuate hepatic stellate cells activation and liver fibrosis
ATG or post-transplant cyclophosphamide to prevent GVHD in matched unrelated stem cell transplantation?
Post-transplant cyclophosphamide alters immune signatures and leads to impaired T cell reconstitution in allogeneic hematopoietic stem cell transplant
Strategies in umbilical cord-derived mesenchymal stem cells expansion
Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide for T-Cell Prolymphocytic Leukemia after Alemtuzumab Induction Therapy: A Case Report
Haploidentical Hematopoietic Cell Transplantation Using Posttransplant Cyclophosphamide for Sézary Syndrome
Donor’s age influences outcome in haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide - a single center experience
Umbilical cord-derived mesenchymal stem cell sheets transplanted subcutaneously enhance cell retention and survival more than dissociated stem cell injections
Haploidentical Hematopoietic Stem Cell Transplantation Followed by ‘Post-Cyclophosphamide’: The Future of Allogeneic Stem Cell Transplant
Dual T-cell depletion with individually tailored anti-thymocyte globulin and attenuated dose of post-transplant cyclophosphamide in haploidentical peripheral stem cell transplantation
Post-transplant cyclophosphamide and sirolimus based graft-versus-host disease prophylaxis after allogeneic stem cell transplantation for acute myeloid leukemia
Platelet lysate induces chondrogenic differentiation of umbilical cord-derived mesenchymal stem cells
Human umbilical cord-derived mesenchymal stem cells attenuate hepatic stellate cells activation and liver fibrosis
ATG or post-transplant cyclophosphamide to prevent GVHD in matched unrelated stem cell transplantation?
Post-transplant cyclophosphamide alters immune signatures and leads to impaired T cell reconstitution in allogeneic hematopoietic stem cell transplant
Strategies in umbilical cord-derived mesenchymal stem cells expansion
Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide for T-Cell Prolymphocytic Leukemia after Alemtuzumab Induction Therapy: A Case Report
Haploidentical Hematopoietic Cell Transplantation Using Posttransplant Cyclophosphamide for Sézary Syndrome
Donor’s age influences outcome in haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide - a single center experience
Umbilical cord-derived mesenchymal stem cell sheets transplanted subcutaneously enhance cell retention and survival more than dissociated stem cell injections
Haploidentical Hematopoietic Stem Cell Transplantation Followed by ‘Post-Cyclophosphamide’: The Future of Allogeneic Stem Cell Transplant
Dual T-cell depletion with individually tailored anti-thymocyte globulin and attenuated dose of post-transplant cyclophosphamide in haploidentical peripheral stem cell transplantation
Post-transplant cyclophosphamide and sirolimus based graft-versus-host disease prophylaxis after allogeneic stem cell transplantation for acute myeloid leukemia
Platelet lysate induces chondrogenic differentiation of umbilical cord-derived mesenchymal stem cells